Neurodevelopmental and neurodegenerative diseases - Is there a pathophysiological link? Attention-deficit/hyperactivity disorder and amyotrophic lateral sclerosis as examples

Medical Hypotheses

Volumn 70, Issue 6, 2008, Pages 1133-1138

  Lule, D ^a   Ludolph, A C ^a   Ludolph, A G ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR; BRAIN REGION; CLINICAL FEATURE; COGNITION; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; HUMAN; NEUROBIOLOGY; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AMYOTROPHIC LATERAL SCLEROSIS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; HUMANS; MODELS, NEUROLOGICAL; NEUROBIOLOGY; NEURODEGENERATIVE DISEASES; RISK FACTORS;

EID: 43049163841     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.11.002     Document Type: Article

References (58)

1. Barkley R.A. Issues in the diagnosis of attention-deficit/hyperactivity disorder in children. Brain Dev 25 2 (2003) 77-83
2. Spencer T.J., Biederman J., and Mick E. Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology. J Pediatr Psychol 32 6 (2007) 631-642
3. Murphy J., Henry R., and Lomen-Hoerth C. Establishing subtypes of the continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol 64 3 (2007) 330-334
4. Kessler R.C., Adler L., Barkley R., et al. The prevalence and correlates of adult ADHD in the United States: results from the national comorbidity survey replication. Am J Psychiatry 163 (2006) 716-723
5. Boonstra A.M., Kooij J.J., Oosterlaan J., Sergeant J.A., Buitelaar J.K., and van Someren E.J. Hyperactive night and day? Actigraphy studies in adult ADHD: a baseline comparison and the effect of methylphenidate. Sleep 30 4 (2007) 433-442
6. Stabeno M.E. The ADHD affected athlete (2004), Trafford Publishing, Victoria
7. Scarmeas N., Shih T., Stern Y., Ottman R., and Rowland L.P. Premorbid weight, body mass, and varsity athletics in ALS. Neurology 59 5 (2002) 773-775
8. St Louis E.K. Musical tradition, insurrection, and resurrection: the life and legacy of composer/bassist Charles Mingus. Semin Neurol 19 1 (1999) 25-28
9. Young J.M., and McNicoll P. Against all odds: positive life experiences of people with advanced amyotrophic lateral sclerosis. Health Soc Work 23 1 (1998) 35-43
10. Veldink J.H., Kalmijn S., Groeneveld G.J., Titulaer M.J., Wokke J.H., and van den Berg L.H. Physical activity and the association with sporadic ALS. Neurology 64 2 (2005) 241-245
11. Chiò A., Benzi G., Dossena M., Mutani R., and Mora G. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain 128 3 (2005) 472-476 Epub 2005 Jan 5
12. Taioli E. All causes mortality in male professional soccer players. Eur J Public Health. Epub 2007 April 12.
13. Vanacore N., Binazzi A., Bottazzi M., and Belli S. Amyotrophic lateral sclerosis in an Italian professional soccer player. Parkinsonism Relat Disord 12 5 (2006) 327-329 Epub 2006 Feb 3
14. Wicks P., Ganesalingham J., Collin C., Prevett M., Leigh N.P., and Al-Chalabi A. Three soccer playing friends with simultaneous amyotrophic lateral sclerosis. Amyotroph Lateral Scler 8 3 (2007) 177-179
15. Abel E.L. Football increases the risk for Lou Gehrig's disease, amyotrophic lateral sclerosis. Percept Mot Skills 104 3-2 (2007) 1251-1254
16. Kihira T., Kanno S., Miwa H., Okamoto K., and Kondo T. The role of exogenous risk factors in amyotrophic lateral sclerosis in Wakayama, Japan. Amyotroph Lateral Scler 8 3 (2007) 150-156
17. Weisskopf M.G., McCullough M.L., Morozova N., Calle E.E., Thun M.J., and Ascherio A. Prospective study of occupation and amyotrophic lateral sclerosis mortality. Am J Epidemiol 162 12 (2005) 1146-1152 Epub 2005 Nov 3
18. Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ. Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 1999;18-25 354(9196):2132-3.
19. Krause K.H., Dresel S.H., Krause J., Kung H.F., and Tatsch K. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett 285 (2000) 107-110
20. Jucaite A., Fernell E., Halldin C., Forssberg H., and Farde L. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity. Biol Psychiatry 57 (2005) 229-238
21. Yang B., Chan R.C., Jing J., Li T., Sham P., and Chen R.Y. A meta-analysis of association studies between the 10-repeat allele of a VNTR polymorphism in the 3'-UTR of dopamine transporter gene and attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 144 4 (2007) 541-550
22. Roman T., Rohde L.A., and Hutz M.H. Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder. Am J Pharmacogenomics 4 2 (2004) 83-92
23. Volkow N.D., Wang G.J., Newcorn J., et al. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 64 8 (2007) 932-940
24. Borasio G.D., Linke R., Schwarz J., et al. Dopaminergic deficit in amyotrophic lateral sclerosis assessed with [I-123] IPT single photon emission computed tomography. J Neurol Neurosurg Psychiatry 65 (1998) 263-265
25. Kato S., Oda M., and Tanabe H. Diminution of dopaminergic neurons in the substantia nigra of sporadic amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 19 4 (1993) 300-304
26. Takahashi H., Snow B.J., Bhatt M.H., Peppard R., Eisen A., and Calne D.B. Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning. Lancet 342 8878 (1993) 1016-1018
27. Volkow N.D., Wang G.J., Fowler J.S., et al. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications. Synapse 43 (2002) 181-187
28. Carrey N.J., MacMaster F.P., Gaudet L., and Schmidt M.H. Striatal creatine and glutamate/glutamine in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 17 1 (2007) 11-17
29. Vogels O.J., Oyen W.J., van Engelen B.G., Padberg G.W., and Horstink M.W. Decreased striatal dopamine-receptor binding in sporadic ALS: glutamate hyperactivity?. Neurology 52 6 (1999) 1275-1277
30. Moore C.M., Biederman K., Wozniak J., et al. Differences in brain chemistry in children and adolescents with attention deficit hyperactivity disorder with and without comorbid bipolar disorder: a proton magnetic resonance spectroscopy study. Am J Psychiatry 163 2 (2006) 316-318
31. Dorval K.M., Wigg K.G., Crosbie J., et al. Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorder. Genes Brain Behav 6 5 (2007) 444-452
32. Findling R.L., McNamara N.K., Stansbrey R.J., et al. A pilot evaluation of the safety, tolerability, pharmacokinetics, and effectiveness of memantine in pediatric patients with attention-deficit/hyperactivity disorder combined type. J Child Adolesc Psychopharmacol 17 1 (2007) 19-33
33. Ionov I.D. Survey of ALS-associated factors potentially promoting Ca(2+) overload of motor neurons. Amyotroph Lateral Scler 8 5 (2007) 260-265
34. Kuner R., Groom A.J., Müller G., et al. Mechanisms of disease: motoneuron disease aggravated by transgenic expression of a functionally modified AMPA receptor subunit. Ann N Y Acad Sci 1053 (2005) 269-286
35. Van Damme P., Braeken D., Callewaert G., Robberecht W., and Van Den Bosch L. GluR2 deficiency accelerates motor neuron degeneration in a mouse model of amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 64 7 (2005) 605-612
36. Zanette G., Tamburin S., Manganotti P., Refatti N., Forgione A., and Rizzuto N. Different mechanisms contribute to motor cortex hyperexcitability in amyotrophic lateral sclerosis. Clin Neurophysiol 113 11 (2002) 1688-1697
37. Ziemann U., Winter M., Reimers C.D., Reimers K., Tergau F., and Paulus W. Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosis. Evidence from paired transcranial magnetic stimulation. Neurology 49 5 (1997) 1292-1298
38. Yi J.H., and Hazell A.S. Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury. Neurochem Int 48 5 (2006) 394-403 Epub 2006 Feb 13
39. Levin H., Hanten G., Max J., et al. Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children. J Dev Behav Pediatr 28 2 (2007) 108-118
40. Chen H., Richard M., Sandler D.P., Umbach D.M., and Kamel F. Head injury and amyotrophic lateral sclerosis. Am J Epidemiol 166 7 (2007) 810-816 Epub 2007 Jul 19
41. Pineda D.A., Puerta I.C., Aguirre D.C., García-Barrera M.A., and Kamphaus R.W. The role of neuropsychologic tests in the diagnosis of attention deficit hyperactivity disorder. Pediatr Neurol 36 6 (2007) 373-381
42. Miller S.R., Miller C.J., Bloom J.S., Hynd G.W., and Craggs J.G. Right hemisphere brain morphology, attention-deficit hyperactivity disorder (ADHD) subtype, and social comprehension. J Child Neurol 21 2 (2006) 139-144
43. Ludolph A.C., Langen K.J., Regard M., et al. Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study. Acta Neurol Scand 85 2 (1992) 81-89
44. Lule D., Kurt A., Jürgens R., et al. Emotional responding in amyotrophic lateral sclerosis. J Neurol 252 12 (2005) 1517-1524 Epub 2005 Jun 24
45. Schreiber H., Gaigalat T., Wiedemuth-Catrinescu U., et al. Cognitive function in bulbar- and spinal-onset amyotrophic lateral sclerosis. A longitudinal study in 52 patients. J Neurol 252 7 (2005) 772-781 Epub 2005 Mar 8
46. Pinkhardt E, Jürgens R, Graf M et al. Electrophysiologic correlates of selective attention in patients with amyotrophic lateral sclerosis (ALS). Poster 2002; Konferenz EFNS, Wien, Österreich.
47. Vieregge P., Wauschkuhn B., Heberlein I., Hagenah J., and Verleger R. Selective attention is impaired in amyotrophic lateral sclerosis - a study of event-related EEG potentials. Brain Res Cogn Brain Res 8 1 (1999) 27-35
48. Lulé D., Diekmann V., Anders S., et al. Brain responses to emotional stimuli in patients with amyotrophic lateral sclerosis (ALS). J Neurol 254 4 (2007) 519-527 Epub 2007 Mar 31
49. Lulé D. Kortikale Plastizität bei progressiver neuronaler Degeneration - Untersuchungen bei Patienten mit Amyotropher Lateralsklerose. Dissertation 2006, University of Tübingen.
50. Goksøyr PK, Nøttestad JA. The burden of untreated ADHD among adults: the role of stimulant medication. Addict Behav 2007; (Epub ahead of print).
51. Scheres A., Milham M.P., Knutson B., and Castellanos F.X. Ventral striatal hyporesponsiveness during reward anticipation in attention-deficit/hyperactivity disorder. Biol Psychiatry 61 5 (2007) 720-724
52. Plessen K.J., Bansal R., Zhu H., et al. Hippocampus and amygdala morphology in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 63 (2006) 795-807
53. Pinkhardt E.H., Tebartz van Elst L., Ludolph A.C., and Kassubek J. Amygdala size in amyotrophic lateral sclerosis without dementia: an in vivo study using MRI volumetry. BMC Neurol 6 (2006) 48
54. Ludolph A.C., Elger C.E., Böttger I.W., Kuttig A.G., Lottes G., and Brune G.G. N-isopropyl-p-123I-amphetamine single photon emission computer tomography in motor neuron disease. Eur Neurol 29 5 (1989) 255-260
55. Rudnicki S.A., Archer R.L., and Labib B.T. Motor neuron disease in methamphetamine abusers. Amyotroph Lateral Scler 8 2 (2007) 126-127
56. Sinn N., and Bryan J. Effect of supplementation with polyunsaturated fatty acids and micronutrients on learning and behaviour problems associated with child ADHD. J Dev Behav Pedeatr 28 2 (2007) 139-144
57. Ascherio A., Weisskopf M.G., O'reilly E.J., et al. Vitamin E intake and risk of amyotrophic lateral sclerosis. Ann Neurol 57 1 (2005) 104-110
58. Veldink J.H., Kalmijn S., Groeneveld G.J., et al. Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 78 4 (2007) 367-371 Epub 2006 Apr